Sanofi Pasteur, the vaccines unit of Paris-based Sanofi, will pay $19.8 million as part of a settlement for improperly calculating drug prices and overcharging the U.S. Department of Veterans Affairs.
Here are four things to know.
1. Drugmakers are prohibited from charging the VA more than a maximum amount — or federal ceiling price — for covered drugs under the Veterans Health Care Act.
2. Swiftwater, Pa.-based Sanofi Pasteur informed the VA it miscalculated the federal ceiling price for various drugs from 2002 to 2011, thereby overcharging the VA, according to the DOJ.
3. Along with paying the $19.8 million settlement amount, Sanofi Pasteur agreed not to pursue reimbursement claims for the sale of drugs it undercharged the VA for due to the miscalculation.
4. Sanofi Pasteur "cooperated fully and negotiated in good faith with the government," a company spokeswoman told Reuters via email.
More articles on supply chain:
Boston Scientific to buy Swiss devicemaker for $435M
How SSM Health's pharmacy concierge program helps patients manage high drug costs
Viewpoint: US should strengthen existing laws to lower drug prices — not make new ones